CHU de Limoges - Fédération Hépatologie

Limoges 87000

0 studies enrolling now · 2 studies all time

What they study most

Amyloidosis, Smoldering Multiple Myeloma

Studies at this site

• A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis — Completed